Since his initial diagnosis in December 2013, MRF Board Chair and stage 4 melanoma survivor Doug Brodman has helped others understand the value of education, research, and ...

The incorporation of circulating tumor DNA (ctDNA) testing into standard practice for patients with metastatic uveal melanoma receiving tebentafusp-tebn (Kimmtrak) may prov...

Guest blog by Karen Kaludov, an ocular melanoma survivor and advocate who shares her journey after her recent diagnosed in 2021:   Roughly 2,000 people in the US each ...

Guest blog by Patrick Guddal, a stage 3 melanoma survivor and advocate who shares his journey after being diagnosed in 2016: In the spring of 2016, I felt a small bump on m...

The American Association of Cancer Research (AACR) recently named a current and former member of the MRF Breakthrough Consortium as Fellows in the AACR Academy. MRF-support...

Guest blog post by Teddi Mellencamp Arroyave, TV Personality, Wellness Coach, host of the top-rated podcast Two Ts in a Pod, stage II melanoma survivor and advocate: The mo...

Washington, DC (April 20, 2023) – The Melanoma Research Foundation (MRF) is proud to announce the return of their Washington, DC Miles for Melanoma 5K event, held Sat...

An experimental mRNA vaccine developed by Moderna, Inc. and Merck shows significant potential to reduce the risk of recurrence or death in melanoma patients. According to c...

The New England Journal of Medicine (NEJM) recently published a major report announcing a treatment advancement for the melanoma community, particularly patients with rese...

Guest blog by Toni English, a Sinonasal Mucosal Melanoma survivor who was diagnosed in 2015: Toni English grew up in a military family and traveled all over the US and to J...

Guest blog by Katie Doble, ocular melanoma (OM) survivor, MRF Courage Award recipient and OM advocate who shares her journey with Brain mets: Not to brag, but I was a 1A. I...